Page 111 - New epidemiological and PSMA-expression based paradigms in salivary gland tumors
P. 111

Distribution of PSMA-ligand in salivary and lacrimal glands on PET/CT
References
1. Afshar-Oromieh A, Hetzheim H, Kratochwil C, et al. The novel theranostic PSMA-ligand PSMA-617 in the diagnosis of prostate cancer by PET/CT: biodistribution in humans, radiation dosimetry and first evaluation of tumor lesions. J Nucl Med. 2015;56(11):1697-1705. doi:10.2967/jnumed.115.161299.
2. Rahbar K, Ahmadzadehfar H, Kratochwil C, et al. German multicenter study investigating 177Lu- PSMA-617 radioligand therapy in advanced prostate cancer patients. J Nucl Med. 2017;85(1):85-90. doi:10.2967/jnumed.116.183194.
3. Gensheimer MF, Liao JJ, Garden AS, et al. Submandibular gland-sparing radiation therapy for locally advanced oropharyngeal squamous cell carcinoma: patterns of failure and xerostomia outcomes. Radiat Oncol. 2014;9(1):255. doi:10.1186/s13014-014-0255-x.
4. Afzelius P, Nielsen M-Y, Ewertsen C, Bloch KP. Imaging of the major salivary glands. Clin Physiol Funct Imaging. 2016;36(1):1-10. doi:10.1111/cpf.12199.
5. La’Porte SJ, Juttla JK, Lingam RK. Imaging the Floor of the Mouth and the Sublingual Space. Radiographics. 2011;31(5):1215-1230.
6. Mandel ID. The role of saliva in maintaining oral homeostasis. J Am Dent Assoc. 1989;119(2):298-304. doi:10.14219/jada.archive.1989.0211.
7. Hand AR, Pathmanathan D, Field RB. Morphological features of the minor salivary glands. Arch Oral Biol. 1999;44:S3-S10. doi:10.1016/S0003-9969(99)90002-X.
8. Boellaard R, Delgado-Bolton R, Oyen WJG, et al. FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging. 2015;42(2):328-354. doi:10.1007/s00259- 014-2961-x.
9. Kirchner J, Schaarschmidt BM, Sawicki LM, et al. Evaluation of Practical Interpretation Hurdles in 6 68Ga-PSMA PET/CT in 55 Patients: Physiological Tracer Distribution and Incidental Tracer Uptake.
Clin Nucl Med. 2017;42(7):e322-e327. doi:10.1097/RLU.0000000000001672.
10. Demirci E, Sahin OE, Ocak M, Akovali B, Nematyazar J, Kabasakal L. Normal distribution pattern and physiological variants of 68Ga-PSMA-11 PET/CT imaging. Nucl Med Commun. 2016;37(11):1169- 1179. doi:10.1097/MNM.0000000000000566.
11. Bailey B, Calhoun K. Head and Neck Surgery Otolaryngology, Vol 1. 3rd ed. Philadelphia: Lippincot Williams&Wilkins.; 2001.
12. Tos M. Mucous glands in the developing human rhinopharynx. Laryngoscope. 1977;87(6):987-995. doi:10.1288/00005537-197706000-00016.
13. Wang X, Meng L, Hou T, Zheng C, Huang S. Frequency and Distribution Pattern of Minor Salivary Gland Tumors in a Northeastern Chinese Population: A Retrospective Study of 485 Patients. J Oral Maxillofac Surg. 2015;73(1):81-91. doi:10.1016/j.joms.2014.08.019.
14. Horoszewicz JS, Kawinsky E MG. Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients. Anticancer Res. 1987;7(5B):927-935.
15. Israeli RS, Powell CT, Fair WR, Heston WD. Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen. Cancer Res. 1993;53(2):227-230.
16. Wright GL, Haley C, Beckett M Lou, Schellhammer PF. Expression of prostate-specific membrane antigen in normal, benign, and malignant prostate tissues. Urol Oncol Semin Orig Investig. 1995;1(1):18- 28. doi:10.1016/1078-1439(95)00002-Y.
17. Lopes AD, Davis WL, Rosenstraus MJ, Uveges AJ, Gilman SC. Immunohistochemical and Pharmacokinetic Characterization of the Site-specific Immunoconjugate CYT-356 Derived from Antiprostate Monoclonal Antibody 7E11-C5. Cancer Res. 1990;50(19):6423-6429.
18. Israeli RS, Powell CT, Corr JG, Fair WR, Heston WD. Expression of the prostate-specific membrane antigen. Cancer Res. 1994;54(7):1807-1811.
19. Ristau BT, O’Keefe DS, Bacich DJ. The prostate-specific membrane antigen: Lessons and current clinical implications from 20 years of research. Urol Oncol Semin Orig Investig. 2014;32(3):272-279. doi:10.1016/j.urolonc.2013.09.003.
20. Troyer JK, Beckett ML, Wright GL. Detection and characterization of the prostate-specific membrane antigen (PSMA) in tissue extracts and body fluids. Int J cancer. 1995;62(5):552-558.
109
 










































































   109   110   111   112   113